BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liao Y, Lu B, Ma Q, Wu G, Lai X, Zang J, Shi Y, Liu D, Han F, Zhou N. Human Neuropeptide S Receptor Is Activated via a Gαq Protein-biased Signaling Cascade by a Human Neuropeptide S Analog Lacking the C-terminal 10 Residues. J Biol Chem 2016;291:7505-16. [PMID: 26865629 DOI: 10.1074/jbc.M115.704122] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Harris JA, Faust B, Gondin AB, Dämgen MA, Suomivuori CM, Veldhuis NA, Cheng Y, Dror RO, Thal DM, Manglik A. Selective G protein signaling driven by substance P-neurokinin receptor dynamics. Nat Chem Biol 2021. [PMID: 34711980 DOI: 10.1038/s41589-021-00890-8] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
2 Fang C, Zhang J, Wan Y, Li Z, Qi F, Dang Y, Li J, Wang Y. Neuropeptide S (NPS) and its receptor (NPSR1) in chickens: cloning, tissue expression, and functional analysis. Poult Sci 2021;100:101445. [PMID: 34634709 DOI: 10.1016/j.psj.2021.101445] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Tobinski AM, Rappeneau V. Role of the Neuropeptide S System in Emotionality, Stress Responsiveness and Addiction-Like Behaviours in Rodents: Relevance to Stress-Related Disorders. Pharmaceuticals (Basel) 2021;14:780. [PMID: 34451877 DOI: 10.3390/ph14080780] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
4 Park S, Flüthmann P, Wolany C, Goedecke L, Spenner HM, Budde T, Pape HC, Jüngling K. Neuropeptide S Receptor Stimulation Excites Principal Neurons in Murine Basolateral Amygdala through a Calcium-Dependent Decrease in Membrane Potassium Conductance. Pharmaceuticals (Basel) 2021;14:519. [PMID: 34072275 DOI: 10.3390/ph14060519] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Patt J, Alenfelder J, Pfeil EM, Voss JH, Merten N, Eryilmaz F, Heycke N, Rick U, Inoue A, Kehraus S, Deupi X, Müller CE, König GM, Crüsemann M, Kostenis E. An experimental strategy to probe Gq contribution to signal transduction in living cells. J Biol Chem 2021;296:100472. [PMID: 33639168 DOI: 10.1016/j.jbc.2021.100472] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
6 Schlegel JG, Tahoun M, Seidinger A, Voss JH, Kuschak M, Kehraus S, Schneider M, Matthey M, Fleischmann BK, König GM, Wenzel D, Müller CE. Macrocyclic Gq Protein Inhibitors FR900359 and/or YM-254890-Fit for Translation? ACS Pharmacol Transl Sci 2021;4:888-97. [PMID: 33860209 DOI: 10.1021/acsptsci.1c00021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
7 Davenport AP, Scully CCG, de Graaf C, Brown AJH, Maguire JJ. Advances in therapeutic peptides targeting G protein-coupled receptors. Nat Rev Drug Discov. 2020;19:389-413. [PMID: 32494050 DOI: 10.1038/s41573-020-0062-z] [Cited by in Crossref: 42] [Cited by in F6Publishing: 76] [Article Influence: 21.0] [Reference Citation Analysis]
8 Kostenis E, Pfeil EM, Annala S. Heterotrimeric Gq proteins as therapeutic targets? J Biol Chem 2020;295:5206-15. [PMID: 32122969 DOI: 10.1074/jbc.REV119.007061] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
9 Lu L, Wu ZY, Li X, Han F. State-of-the-art: functional fluorescent probes for bioimaging and pharmacological research. Acta Pharmacol Sin 2019;40:717-23. [PMID: 30487651 DOI: 10.1038/s41401-018-0190-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
10 Malfacini D, Patt J, Annala S, Harpsøe K, Eryilmaz F, Reher R, Crüsemann M, Hanke W, Zhang H, Tietze D, Gloriam DE, Bräuner-Osborne H, Strømgaard K, König GM, Inoue A, Gomeza J, Kostenis E. Rational design of a heterotrimeric G protein α subunit with artificial inhibitor sensitivity. J Biol Chem 2019;294:5747-58. [PMID: 30745359 DOI: 10.1074/jbc.RA118.007250] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
11 Ruzza C, Ferrari F, Guerrini R, Marzola E, Preti D, Reinscheid RK, Calo G. Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies. Pharmacol Res Perspect 2018;6:e00445. [PMID: 30534379 DOI: 10.1002/prp2.445] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
12 Li S, Pan H, Tan C, Sun Y, Song Y, Zhang X, Yang W, Wang X, Li D, Dai Y, Ma Q, Xu C, Zhu X, Kang L, Fu Y, Xu X, Shu J, Zhou N, Han F, Qin D, Huang W, Liu Z, Yan Q. Mitochondrial Dysfunctions Contribute to Hypertrophic Cardiomyopathy in Patient iPSC-Derived Cardiomyocytes with MT-RNR2 Mutation. Stem Cell Reports 2018;10:808-21. [PMID: 29456182 DOI: 10.1016/j.stemcr.2018.01.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 38] [Article Influence: 6.8] [Reference Citation Analysis]
13 Grund T, Goyon S, Li Y, Eliava M, Liu H, Charlet A, Grinevich V, Neumann ID. Neuropeptide S Activates Paraventricular Oxytocin Neurons to Induce Anxiolysis. J Neurosci 2017;37:12214-25. [PMID: 29118105 DOI: 10.1523/JNEUROSCI.2161-17.2017] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
14 Grund T, Neumann ID. Neuropeptide S Induces Acute Anxiolysis by Phospholipase C-Dependent Signaling within the Medial Amygdala. Neuropsychopharmacology 2018;43:1156-63. [PMID: 28805209 DOI: 10.1038/npp.2017.169] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
15 Acevedo N, Ezer S, Kebede Merid S, Gaertner VD, Söderhäll C, D'Amato M, Kabesch M, Melén E, Kere J, Pulkkinen V. Neuropeptide S (NPS) variants modify the signaling and risk effects of NPS Receptor 1 (NPSR1) variants in asthma. PLoS One 2017;12:e0176568. [PMID: 28463995 DOI: 10.1371/journal.pone.0176568] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
16 Clark SD, Kenakin TP, Gertz S, Hassler C, Gay EA, Langston TL, Reinscheid RK, Runyon SP. Identification of the first biased NPS receptor agonist that retains anxiolytic and memory promoting effects with reduced levels of locomotor stimulation. Neuropharmacology 2017;118:69-78. [PMID: 28267583 DOI: 10.1016/j.neuropharm.2017.03.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]